Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.600
+0.050 (3.23%)
At close: Feb 11, 2026, 4:00 PM EST
1.618
+0.018 (1.13%)
After-hours: Feb 11, 2026, 7:51 PM EST

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $120.00K in the quarter ending September 30, 2025, a decrease of -27.27%. This brings the company's revenue in the last twelve months to $501.00K, down -27.29% year-over-year. In the year 2024, Cardiff Oncology had annual revenue of $683.00K with 39.96% growth.

Revenue (ttm)
$501.00K
Revenue Growth
-27.29%
P/S Ratio
202.92
Revenue / Employee
$15,182
Employees
33
Market Cap
107.78M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024683.00K195.00K39.96%
Dec 31, 2023488.00K102.00K26.42%
Dec 31, 2022386.00K27.00K7.52%
Dec 31, 2021359.00K-7.00K-1.91%
Dec 31, 2020366.00K121.37K49.61%
Dec 31, 2019244.63K-133.69K-35.34%
Dec 31, 2018378.33K-127.08K-25.14%
Dec 31, 2017505.40K124.33K32.63%
Dec 31, 2016381.07K68.26K21.82%
Dec 31, 2015312.81K32.63K11.65%
Dec 31, 2014280.18K20.93K8.07%
Dec 31, 2013259.25K-191.16K-42.44%
Dec 31, 2012450.40K192.71K74.78%
Dec 31, 2011257.70K-273.63K-51.50%
Dec 31, 2010531.33K--